Christine Lebrun-Frenay

54PUBLICATIONS
205CO-AUTHORS
Medical infection agents (incl. prions)Gene and molecular therapyPredictive and prognostic markersOptical technologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (54)

|Sep 26, 2026
Serum GFAP and Age Accurately Distinguish AQP4-IgG Positive and Double Seronegative NMOSD From MOGAD After a Recent Attack.

|Aug 14, 2026
Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.

|Aug 14, 2026
Anti-CD20 Discontinuation Versus Continuation in People Aged Over 50 With Non-Active Multiple Sclerosis.

|Jun 02, 2026
Subclinical Optic Nerve Involvement in Radiologically Isolated Syndrome: Multimodal Detection and Diagnostic Impact.

|Jun 02, 2026
A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis.

|May 29, 2026
Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term Disability.

Pageof 9

Frequent Collaborators

18 joint publications

Eric Thouvenot

18 joint publications

Jonathan Ciron

17 joint publications

Sandra Vukusic

16 joint publications

Elisabeth Maillart